Kelly M Hensley

发表

Differential Expression of the Cyclic GMP-stimulated Phosphodiesterase PDE2A in Human Venous and Capillary Endothelial Cells

K. Sadhu, Kelly Hensley, S. Wolda, 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Off-Target Platelet Activation in Macaques Unique to a Therapeutic Monoclonal Antibody

Sean P. Lear, J. Reindel, D. Rock, 2012, Toxicologic pathology.

In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic Regulator*

W. Richards, M. Ollmann, I. Rulifson, 2016, The Journal of Biological Chemistry.

Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.

W. Richards, M. Stolina, J. Tomlinson, 2017, Bone.

Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism

W. Richards, M. Stolina, J. Tomlinson, 2017, Calcified Tissue International.

Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid Leukemia

T. Arvedson, O. Homann, H. Lebrec, 2020, Toxicological sciences : an official journal of the Society of Toxicology.

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1.

Dirk E. Smith, Randal R Ketchem, Yang-yang Huang, 2009, Immunity.

854 SGN-B7H4V, a novel, investigational vedotin antibody-drug conjugate directed to the T cell checkpoint ligand B7-H4, shows promising activity in preclinical models

P. Treuting, R. Boyce, Jason P. Schrum, 2021, Journal for ImmunoTherapy of Cancer.

CD11c/CD18: novel ligands and a role in delayed‐type hypersensitivity

S. Simon, D. Staunton, Harold J. Ting, 2007, Journal of leukocyte biology.

CD 11 c / CD 18 : novel ligands and a role in delayed-type hypersensitivity

S. Simon, D. Staunton, Harold J. Ting, 2007 .

Abstract 1140: Enfortumab vedotin, a Nectin-4 directed ADC, demonstrates compelling tolerability and anti-tumor activity with intravesical instillation in preclinical models of non-muscle invasive bladder cancer

Lauren Farr, E. Trueblood, S. Sandall, 2022, Cancer Research.

1187 Enfortumab vedotin induces immunogenic cell death, elicits antitumor immune memory, and shows enhanced preclinical activity in combination with immune checkpoint inhibitors

A. Nesterova, T. Lewis, Taisuke Nakazawa, 2022, Regular and Young Investigator Award Abstracts.

Abstract 5581: Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers

A. Nesterova, T. Lewis, Bernard A. Liu, 2020 .

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

Dirk E. Smith, J. Johnston, O. Homann, 2018, bioRxiv.

SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models

A. Nesterova, T. Lewis, N. Okeley, 2023, Molecular cancer therapeutics.

PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater

Hantao Liu, L. Edvinsson, K. Page, 2018, Cephalalgia : an international journal of headache.

GPR34 is not required for mast cell degranulation induced by IgE or lysophosphatidyl-L-serine (36.1)

C. Vissinga, J. Kirchner, Kelly M Hensley, 2009, The Journal of Immunology.